Parmax Pharma Ltd
BSE:
NSE:
null Share Price
BSE:
NSE:
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹16.06Cr
Parmax Pharma Ltd Performance
▲
▲
▲
▲
Parmax Pharma Ltd Fundamentals
Parmax Pharma Ltd Delivery and Volume
About Parmax Pharma Ltd
Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations.
The Pr
| Name | Designation |
|---|---|
| Umang Alkesh Gosalia | Managing Director |
| Ami R Shah | Non-Exec. & Independent Dir. |
| Nikhil S. Uchat | Non-Exec. & Independent Dir. |
| Bhakti Rameshbhai Aghera | Company Sec. & Compli. Officer |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Parmax Pharma Ltd FAQs
How do I Buy Parmax Pharma Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Parmax Pharma Ltd shares in BlinkX.
What is the Share Price of Parmax Pharma Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Parmax Pharma Ltd's share price is ₹42.93 as of 2025-02-22.
What is the PE ratio of Parmax Pharma Ltd?
Parmax Pharma Ltd's P/E ratio is - times as of 2025-02-22.
What is the PB ratio of Parmax Pharma Ltd?
Parmax Pharma Ltd's most recent financial reports indicate a price-to-book ratio of -, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Parmax Pharma Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Parmax Pharma Ltd's market capitalization is ₹16.06 Cr as on 2025-02-22.
What is the ROE of Parmax Pharma Ltd?
The current financial records of Parmax Pharma Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Parmax Pharma Ltd?
According to Parmax Pharma Ltd's most recent financial filings, the company has a total asset value of ₹5.77, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Parmax Pharma Ltd?
The 52-week high/low price of a Parmax Pharma Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Parmax Pharma Ltd's 52-week high and low as of 2025-02-22 are ₹44.71 and ₹42.79, respectively.
